PRDX6 and brain infarction: However, combined treatment with Prdx6 siRNA and Prdx6-iPLA2 inhibitor MJ33 showed a greater diminution in neurologic deficits, cerebral infarction, brain water content and inflammatory molecules than Prdx6-siRNA treatment alone.